Shares of Ocugen, Inc. (OCGN) rose 3% on Friday morning after the company reported a better-than-feared first-quarter (Q1) ...

M ALVERN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced ...

Ocugen, Inc., a biotechnology company focused on gene therapies for blindness diseases, announced its participation in two significant upcoming conferences: the ARVO 2025 Annual Meeting in Salt ...

Stocktwits - As the Indian Q4 earnings season heats up, Tata Consumers, LTI Mindtree (NSE:MINT) and Nestle (NSE:NEST) India have drawn significant attention with their results. The market reaction has ...

Stocktwits - Gold prices in the spot market tumbled 3% on Wednesday after President Donald Trump eased his attacks on Federal Reserve Chair Jerome Powell. Gold was trading at $3,280 an ounce in the ...

In this article, we are going to take a look at where Ocugen Inc. (NASDAQ:OCGN) stands against other penny stocks to invest in under $1. Earlier on February 12 this year, Chief Investment Officer ...

Ocugen Inc. (NASDAQ:OCGN) discovers, develops, and commercializes novel gene and cell therapies, biologics, and vaccines for improving patients’ health. Its innovative gene therapy platform has ...

Wellington Management Group LLP raised its holdings in shares of Ocugen, Inc. (NASDAQ:OCGN – Free Report) by 10.5% in the 4th quarter, Holdings Channel reports.The firm owned 507,495 shares of ...

Shares of Ocugen Inc. OCGN slipped 2.77% to $0.67 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.79% to 5,405.97 and ...